MarketCap
Facebook
X
TelegramQuarterly report 2025-Q1
added 04-22-2025
Danaher Corporation Cash and Cash Equivalents 2011-2026 | DHR
Annual Cash and Cash Equivalents Danaher Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.08 B | 5.86 B | 6 B | 2.59 B | 6.04 B | 19.9 B | 788 M | 630 M | 964 M | 791 M | 3.01 B | 3.12 B | 1.68 B | 537 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 19.9 B | 537 M | 3.86 B |
Quarterly Cash and Cash Equivalents Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.99 B | 2.08 B | 7.03 B | - | - | 3.98 B | 3.72 B | 2.59 B | 2.55 B | 7.32 B | 2.59 B | 6.04 B | 5.69 B | 5.54 B | 4.37 B | 19.9 B | 14.3 B | 19.9 B | 19.9 B | 788 M | 788 M | 788 M | 788 M | 630 M | 630 M | 630 M | 630 M | 964 M | 964 M | 964 M | 964 M | 791 M | 791 M | 791 M | 791 M | 3.01 B | 3.01 B | 3.01 B | 3.01 B | 3.12 B | 3.12 B | 3.12 B | 3.12 B | 1.68 B | 1.68 B | 1.68 B | 1.68 B | 537 M | 537 M | 537 M | 537 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 19.9 B | 537 M | 3.58 B |
Cash and Cash Equivalents of other stocks in the Diagnostics research industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
69.3 M | $ 23.11 | 4.52 % | $ 99.4 M |  Israel |
 |
Accelerate Diagnostics
AXDX
|
34.9 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
1.9 B | $ 23.0 | 2.86 % | $ 248 M |  China |
 |
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
9.17 M | $ 1.6 | -0.22 % | $ 2.03 M | USA |
 |
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
7.7 M | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
14.9 M | $ 6.1 | 1.16 % | $ 179 M | USA |
 |
Castle Biosciences
CSTL
|
120 M | $ 39.93 | -1.67 % | $ 1.11 B | USA |
 |
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M | China |
 |
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | China |
 |
DarioHealth Corp.
DRIO
|
36.8 M | $ 12.98 | 6.97 % | $ 368 M | Israel |
 |
DexCom
DXCM
|
566 M | $ 68.47 | -2.33 % | $ 26.4 B | USA |
 |
CareDx, Inc
CDNA
|
82.2 M | $ 17.5 | -7.41 % | $ 941 M | USA |
 |
Celcuity
CELC
|
22.5 M | $ 105.54 | -3.33 % | $ 4.16 B | USA |
 |
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
1.27 M | $ 3.4 | 3.66 % | $ 108 K | USA |
 |
Exact Sciences Corporation
EXAS
|
601 M | $ 101.77 | 0.14 % | $ 18.9 B | USA |
 |
Fulgent Genetics
FLGT
|
55.1 M | $ 27.9 | -0.39 % | $ 844 M | USA |
 |
Guardant Health
GH
|
526 M | $ 107.75 | -1.98 % | $ 13.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
598 M | $ 48.19 | 1.71 % | $ 10.7 B |  Niderland |
 |
Aspira Women's Health
AWH
|
13.3 M | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
1.13 B | $ 146.41 | -2.48 % | $ 23.3 B | USA |
 |
Charles River Laboratories International
CRL
|
195 M | $ 214.0 | -1.51 % | $ 11 B | USA |
 |
IQVIA Holdings
IQV
|
1.7 B | $ 243.4 | -0.36 % | $ 44.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
549 M | $ 177.06 | -0.64 % | $ 19.7 B | USA |
|
Biodesix
BDSX
|
26.2 M | $ 5.77 | -3.27 % | $ 748 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.52 B | $ 254.76 | 0.43 % | $ 21.4 B | USA |
 |
ICON Public Limited Company
ICLR
|
752 M | $ 189.39 | -6.67 % | $ 15.6 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
288 M | $ 708.9 | -0.79 % | $ 58.5 B | USA |
 |
Lantheus Holdings
LNTH
|
913 M | $ 68.27 | -1.59 % | $ 4.72 B | USA |
 |
Agilent Technologies
A
|
1.48 B | $ 145.56 | -1.51 % | $ 44.3 B | USA |
 |
Biomerica
BMRA
|
2.4 M | $ 2.83 | 1.8 % | $ 6.5 M | USA |
 |
Bioventus
BVS
|
37 M | $ 8.0 | 5.12 % | $ 501 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.4 B | $ 29.47 | 1.25 % | $ 20 B | Niderland |
 |
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | Israel |
 |
Precipio
PRPO
|
1.5 M | $ 23.85 | 2.49 % | $ 31 M | USA |
 |
Mettler-Toledo International
MTD
|
59.4 M | $ 1 461.94 | -0.56 % | $ 31 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
102 M | $ 6.63 | -0.08 % | $ 601 M | USA |
 |
ENDRA Life Sciences
NDRA
|
3.23 M | $ 4.64 | 1.75 % | $ 2.49 M | USA |